Short answer
SHOULDER INNOVATIONS, INC. (SI) filed an 8-K current report with the SEC on October 8, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Limited user release of InSet Go, a next-generation glenoid implant for anatomic shoulder arthroplasty.
SHOULDER INNOVATIONS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Limited user release of InSet Go, a next-generation glenoid implant for anatomic shoulder arthroplasty
- First surgical case successfully completed, supporting transition toward controlled commercial use
- Product launch may expand Shoulder Innovations’ shoulder reconstruction portfolio and surgeon adoption
- Full announcement details in Exhibit 99.1 press release
Item EX-99.1 · Exhibit EX-99.1
- Limited user release launched for InSet Go, the next-generation glenoid implant in anatomic shoulder arthroplasty
- First surgical case completed at University Hospitals Cleveland Medical Center, supporting initial clinical adoption
- Design preserves bone and targets glenoid loosening, a leading failure cause in anatomic shoulder replacement
- Streamlined surgical steps could reduce procedure times and improve operating-room efficiency
- Full commercial introduction planned over coming quarters, creating a future product expansion catalyst
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SHOULDER INNOVATIONS, INC. 8-K filings
Get the next SI 8-K as it lands
Follow SI for push alerts, or ask the research agent what this filing means.